Dr. Amitabh Chandra
Fee $25K - $40K

Dr. Amitabh Chandra

A Harvard professor, teacher, TEDx speaker, economist, consultant and entrepreneur, Amitabh Chandra bridges the worlds of innovation, regulation, and health-policy with sweeping knowledge of state and Federal policy, bio-pharma R&D, and FDA regulation. Congress, investors, private companies and journalists turn to him for a ‘tell it like it is’ approach to improving healthcare and separating actual opportunities from purely aspirational ones.

Ethel Zimmerman Wiener Professor of Public Policy, Harvard Kennedy School; Henry and Allison McCance Professor of Business Administration, Harvard Business School

Expertise In:

  • Communication
  • Health Care Economics
  • Health Care Policy
  • Health Care Sciences
  • Inspiring Lives

Audience & Industry

  • Associations
  • Corporations
  • The Finance Industry
  • The Health Care Industry
  • The Manufacturing Industry

A Harvard professor, teacher, TEDx speaker, economist, consultant and entrepreneur, Amitabh Chandra bridges the worlds of innovation, regulation, and health-policy with sweeping knowledge of state and Federal policy, bio-pharma R&D, and FDA regulation. Congress, investors, private companies and journalists turn to him for a ‘tell it like it is’ approach to improving healthcare and separating actual opportunities from purely aspirational ones.

Professor Chandra studies innovation, productivity, pricing and technology in health care, medical malpractice, and disparities in health care. His research has been published in leading journals such as the American Economic Review, Journal of Political Economy, the New England Journal of Medicine, JAMA, and Health Affairs. Professor Chandra has testified before the US Senate and the US Commission on Civil Rights, and has served as special commissioner on the Massachusetts Special Commission on Provider Price Reform. He is a member of the Congressional Budget Office’s (CBO’s) Panel of Health Advisors, a research associate at the National Bureau of Economic Research (NBER), and an elected member of the National Academy of Medicine and the National Academy of Social Insurance. He is the recipient of the Upjohn Institute Dissertation Award, the Kenneth Arrow Award for best paper in health economics, the Eugene Garfield Award for Economic Impact on Medical Research, the National Institute for Health Care Management (NIHCM) research award, and the American Society of Health Economists’ ASHE Medal.

His interests sit at the intersection of innovation and regulation in healthcare and he has a keen interest in opportunities and challenges that transcend current policy debates and that will need to be tackled by a raft of public and private efforts— like improving quality, reducing the cost of care through competition, being able to encourage innovation— especially in the area of delivery, and treatments for Alzheimer's and oncology, and smarter ways to pay for innovation.

Featured Experiences

Beyond the Affordable Care Act: The Future of Healthcare Reform in the US

In the wake of the upcoming elections, payers, manufacturers, and investors are struggling to make sense of health care reform in the US. We will explore the points of agreement and disagreement between Democrats and Republicans on the reform agenda to make sense of what the future may look like. We will discuss what the ACA achieved and what it did not, contrast it to approaches in Medicare for All proposals, and discuss the evidence for transparency and alternative payment models. The discussion will move onto opportunities and challenges that transcend current policy debates— like improving quality, reducing the cost of care, being able to encourage innovation— especially in the area of delivery, and treatments for Alzheimer’s.

The BioPharma Dilemma: Balancing Innovation and Access

Interactive discussion of the tradeoff between higher rates of innovation from the bio-pharma industry and the challenge of providing access to these innovations. Much of the speech focuses on opportunities to overcome this dilemma.

The Healthcare Trilemma: Access, Quality and Innovation

Interactive discussion of what ails US healthcare with an emphasis on challenges and opportunities for the future.

Featured Videos